Afuco™ Anti-CD33 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-013)

CAT#: AFC-TAB-013

This product is an ADCC enhanced antibody produced by our Afuco™ platform. It is a monoclonal antibody to CD33.

Gene Expression
Figure 1 IF staining of human cell line PC-3 Figure 2 IHC staining of human lymph node Figure 3 IHC staining of human tonsil Figure 4 IF staining of human cell line RH-30 Figure 5 IF staining of human cell line U-2 OS Figure 6 Kidney Figure 7 Lymph node Figure 8 Spleen Figure 9 RNA cell line category: Cell line enhanced (HEL, HL-60, HMC-1, NB-4, RPMI-8226, THP-1, U-937)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized (from mouse)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • IF, IP, Neut, FuncS, ELISA, FC
  • Conjugate
  • Unconjugated
  • Trade name
  • Mylotarg
  • Generic Name
  • Gemtuzumab

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • CD33 molecule; CD33 antigen (gp67); myeloid cell surface antigen CD33; p67; sialic acid binding Ig like lectin 3; SIGLEC 3; SIGLEC3; gp67; sialic acid binding Ig-like lectin 3
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-013. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Excellent for Targeting Cancer Cells
Gemtuzumab has been a game-changer in our lab for targeting CD33-positive cancer cells. Its ability to enhance ADCC helps us study immune responses more effectively, paving the way for potential new therapies.
Breast cancer biomarkers at key points during disease progression
Perfect for Flow Cytometry
We've been using Gemtuzumab in flow cytometry, and the results are consistently precise and clear. It's indispensable for identifying and studying CD33-positive cell populations in our experiments.
Breast cancer biomarkers at key points during disease progression
Advanced Metabolic Studies
Gemtuzumab has facilitated advanced studies on cell metabolism during activation by engaging CD33. Understanding these metabolic pathways is crucial for revealing critical aspects of T-cell function.

Q&As

  1. How does gemtuzumab, also known as AfucoTM Anti-CD33 ADCC Recombinant Antibody, target cancer cells?

    A: Gemtuzumab targets CD33, a protein commonly found on the surface of certain cancer cells, especially in acute myeloid leukemia (AML). It enhances Antibody-Dependent Cellular Cytotoxicity (ADCC), meaning it helps the immune system's natural killer cells to better identify and destroy these cancer cells.

  2. In what ways does gemtuzumab improve research on immune responses directed against cancer cells?

    A: By targeting CD33 and enhancing ADCC, Gemtuzumab allows researchers to study how effectively the immune system's natural killer cells can attack and kill cancer cells, giving a clearer picture of potential immune responses in AML and other CD33-positive cancers.

  3. When compared to other antibodies, what are the advantages of utilizing gemtuzumab in cancer research?

    A: Gemtuzumab is specifically engineered to enhance ADCC, making it more effective in promoting immune-mediated killing of CD33-positive cancer cells. This enhanced activity provides more robust experimental outcomes and greater potential for therapeutic applications.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "CD33"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
NAB-321-sdAb Recombinant Anti-human CD33 VHH Single Domain Antibody WB, IP, ChiP, Neut, ELISA Llama VHH
CAT Product Name Application Type
TAB-013 Humanized Anti-CD33 Recombinant Antibody (TAB-013) IF, IP, Neut, FuncS, ELISA, FC, WB Humanized (from mouse) IgG4, κ
TAB-H37 Anti-Human CD33 Recombinant Antibody (Gemtuzumab Ozogamicin) ELISA, FC, IP, FuncS, IF, Neut, IHC IgG
TAB-756 Anti-CD33 Recombinant Antibody (TAB-756) IF, IP, Neut, FuncS, ELISA, FC, ICC IgG1 - kappa
VS3-WK1523 Human Anti-CD33 Recombinant Antibody (clone CDP-771) FC Humanized IgG4
CAT Product Name Application Type
AGTO-G008E Anti-CD33 immunotoxin (scFv)-PE Cytotoxicity assay, Function study
AGTO-G008G Anti-CD33 immunotoxin (scFv)-Gel Cytotoxicity assay, Function study
AGTO-L050E anti-CD33 immunotoxin M195 (IgG)-PE Cytotoxicity assay, Functional assay
AGTO-L050G anti-CD33 immunotoxin M195 (IgG)-Gel Cytotoxicity assay, Functional assay
CAT Product Name Application Type
Gly-013LC Recombinant Anti-Human CD33 Antibody (Fab glycosylation) ELISA Humanized antibody
CAT Product Name Application Type
NEUT-341CQ Mouse Anti-CD33 Recombinant Antibody (clone WM53) FC, IHC-Fr, ICC, IP, WB, Block Mouse IgG1, κ
CAT Product Name Application Type
MOR-0553 Hi-Affi™ Rabbit Anti-CD33 Recombinant Antibody (clone DS553AB) WB, ICC, IP Rabbit IgG
CAT Product Name Application Type
TAB-471CQ Anti-Human CD33 Recombinant Antibody (TAB-471CQ) ELISA, IHC, FC, IP, IF, FuncS IgG1, κ
CAT Product Name Application Type
AFC-TAB-471CQ Afuco™ Anti-CD33 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-471CQ) ELISA, IHC, FC, IP, IF, FuncS ADCC enhanced antibody
AFC-TAB-756 Afuco™ Anti-CD33 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-756) IF, IP, Neut, FuncS, ELISA, FC ADCC enhanced antibody
CAT Product Name Application Type
VS-0924-YC24 Rabbit Anti-CD33 Antibody (VS-0924-YC24) - Cancer Stem Cell Marker IHC Rabbit IgG
CAT Product Name Application Type
VS-0425-FY84 Mouse Anti-CD33 scFv-Fc Chimera (VS-0425-FY84) FC, IF Mouse IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC365 Recombinant Anti-CD33 Vesicular Antibody, EV Displayed (VS-0425-YC365) ELISA, FC, Neut, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare